Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A.

Acta Oncol. 2019 Jul;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. Epub 2019 Apr 17.

PMID:
30994047
2.

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C.

Cancers (Basel). 2018 Oct 5;10(10). pii: E372. doi: 10.3390/cancers10100372.

3.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.

Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

PMID:
30150718
4.

Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.

Wanner D, Bohn JP, Rudzki J, Stockhammer G, Steurer M.

Ann Hematol. 2019 Jan;98(1):205-207. doi: 10.1007/s00277-018-3381-y. Epub 2018 May 26. No abstract available.

PMID:
29804266
5.

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc.

Bsteh G, Auer M, Iglseder S, Walchhofer LM, Langenscheidt D, Koppi S, Schauer-Maurer G, Stockhammer G, Berger T.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 8;4(2):e323. doi: 10.1212/NXI.0000000000000323. eCollection 2017 Mar. No abstract available.

6.

Serious tumor seeding after brainstem biopsy and its treatment-a case report and review of the literature.

Pinggera D, Kvitsaridtze I, Stockhammer G, Eisner W, Thomé C, Freyschlag CF, Moser P, Kerschbaumer J.

Acta Neurochir (Wien). 2017 Apr;159(4):751-754. doi: 10.1007/s00701-017-3102-7. Epub 2017 Feb 2. Review.

PMID:
28154933
7.

Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.

Hutterer M, Ebner Y, Riemenschneider MJ, Willuweit A, McCoy M, Egger B, Schröder M, Wendl C, Hellwig D, Grosse J, Menhart K, Proescholdt M, Fritsch B, Urbach H, Stockhammer G, Roelcke U, Galldiks N, Meyer PT, Langen KJ, Hau P, Trinka E.

J Nucl Med. 2017 Jan;58(1):129-137. doi: 10.2967/jnumed.116.176610. Epub 2016 Jul 28.

8.

Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.

Bohn JP, Pall G, Stockhammer G, Steurer M.

Target Oncol. 2016 Jun;11(3):263-75. doi: 10.1007/s11523-015-0414-5. Review.

PMID:
26822319
9.

Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report.

Kerschbaumer J, Freyschlag CF, Stockhammer G, Taucher S, Maier H, Thomé C, Seiz-Rosenhagen M.

J Neurosurg. 2016 Jan;124(1):137-40. doi: 10.3171/2014.12.JNS142112. Epub 2015 Jul 10.

PMID:
26162042
10.

Non-convulsive status epilepticus with negative phenomena--a SMART syndrome variant.

Hametner E, Unterberger I, Lutterotti A, Beer R, Prieschl M, Grams AE, Donnemiller E, Stockhammer G.

Seizure. 2015 Feb;25:49-51. doi: 10.1016/j.seizure.2014.12.007. Epub 2014 Dec 23. No abstract available.

11.

Symptoms and medication management in the end of life phase of high-grade glioma patients.

Koekkoek JA, Dirven L, Sizoo EM, Pasman HR, Heimans JJ, Postma TJ, Deliens L, Grant R, McNamara S, Stockhammer G, Medicus E, Taphoorn MJ, Reijneveld JC.

J Neurooncol. 2014 Dec;120(3):589-95. doi: 10.1007/s11060-014-1591-2. Epub 2014 Aug 24.

PMID:
25151506
12.

End of life care in high-grade glioma patients in three European countries: a comparative study.

Koekkoek JA, Dirven L, Reijneveld JC, Sizoo EM, Pasman HR, Postma TJ, Deliens L, Grant R, McNamara S, Grisold W, Medicus E, Stockhammer G, Oberndorfer S, Flechl B, Marosi C, Taphoorn MJ, Heimans JJ.

J Neurooncol. 2014 Nov;120(2):303-10. doi: 10.1007/s11060-014-1548-5. Epub 2014 Jul 20.

PMID:
25038849
13.

Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.

Di Pauli F, Berger T, Walder A, Maier H, Rhomberg P, Uprimny C, Steurer M, Stockhammer G.

J Clin Virol. 2014 Aug;60(4):424-7. doi: 10.1016/j.jcv.2014.05.007. Epub 2014 May 22.

PMID:
24929753
14.

An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.

Nowosielski M, DiFranco MD, Putzer D, Seiz M, Recheis W, Jacobs AH, Stockhammer G, Hutterer M.

PLoS One. 2014 Apr 23;9(4):e95830. doi: 10.1371/journal.pone.0095830. eCollection 2014.

15.

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.

Nowosielski M, Wiestler B, Goebel G, Hutterer M, Schlemmer HP, Stockhammer G, Wick W, Bendszus M, Radbruch A.

Neurology. 2014 May 13;82(19):1684-92. doi: 10.1212/WNL.0000000000000402. Epub 2014 Apr 11.

PMID:
24727314
16.

The end-of-life phase of high-grade glioma patients: a systematic review.

Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ.

Support Care Cancer. 2014 Mar;22(3):847-57. doi: 10.1007/s00520-013-2088-9. Epub 2013 Dec 14. Review.

PMID:
24337718
17.

A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).

Hutterer M, Nowosielski M, Haybaeck J, Embacher S, Stockhammer F, Gotwald T, Holzner B, Capper D, Preusser M, Marosi C, Oberndorfer S, Moik M, Buchroithner J, Seiz M, Tuettenberg J, Herrlinger U, Wick A, Vajkoczy P, Stockhammer G.

Neuro Oncol. 2014 Jan;16(1):92-102. doi: 10.1093/neuonc/not161. Epub 2013 Dec 4.

18.

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Woehrer A, Hackl M, Waldhör T, Weis S, Pichler J, Olschowski A, Buchroithner J, Maier H, Stockhammer G, Thomé C, Haybaeck J, Payer F, von Campe G, Kiefer A, Würtz F, Vince GH, Sedivy R, Oberndorfer S, Marhold F, Bordihn K, Stiglbauer W, Gruber-Mösenbacher U, Bauer R, Feichtinger J, Reiner-Concin A, Grisold W, Marosi C, Preusser M, Dieckmann K, Slavc I, Gatterbauer B, Widhalm G, Haberler C, Hainfellner JA; Austrian Brain Tumour Registry.

Br J Cancer. 2014 Jan 21;110(2):286-96. doi: 10.1038/bjc.2013.714. Epub 2013 Nov 19.

19.

Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature.

Hutterer M, Steurer M, Höftberger R, Hainfellner JA, Pircher A, Nowosielski M, Hau P, Löscher W, Gunsilius E, Berger T, Stockhammer G.

Clin Neuropathol. 2014 Mar-Apr;33(2):143-51. doi: 10.5414/NP300686.

PMID:
24220008
20.

Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.

Hutterer M, Nowosielski M, Putzer D, Fougère Cl, Virgolini IJ, Jacobs AH, Stockhammer G.

Neuro Oncol. 2013 Jul;15(7):814-5. doi: 10.1093/neuonc/not081. Epub 2013 Jun 19. No abstract available.

21.

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

Hutterer M, Nowosielski M, Putzer D, Jansen NL, Seiz M, Schocke M, McCoy M, Göbel G, la Fougère C, Virgolini IJ, Trinka E, Jacobs AH, Stockhammer G.

Neuro Oncol. 2013 Mar;15(3):341-51. doi: 10.1093/neuonc/nos300. Epub 2013 Jan 17.

22.

O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.

Hutterer M, Nowosielski M, Putzer D, Waitz D, Tinkhauser G, Kostron H, Muigg A, Virgolini IJ, Staffen W, Trinka E, Gotwald T, Jacobs AH, Stockhammer G.

J Nucl Med. 2011 Jun;52(6):856-64. doi: 10.2967/jnumed.110.086645.

23.

[Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas].

Holzner B, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Giesinger J.

Wien Med Wochenschr. 2011 Jan;161(1-2):6-12. doi: 10.1007/s10354-011-0872-z. German.

PMID:
21312093
24.

ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.

Nowosielski M, Recheis W, Goebel G, Güler O, Tinkhauser G, Kostron H, Schocke M, Gotwald T, Stockhammer G, Hutterer M.

Neuroradiology. 2011 Apr;53(4):291-302. doi: 10.1007/s00234-010-0808-0. Epub 2010 Dec 2.

25.

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.

Bogdahn U, Hau P, Stockhammer G, Venkataramana NK, Mahapatra AK, Suri A, Balasubramaniam A, Nair S, Oliushine V, Parfenov V, Poverennova I, Zaaroor M, Jachimczak P, Ludwig S, Schmaus S, Heinrichs H, Schlingensiepen KH; Trabedersen Glioma Study Group.

Neuro Oncol. 2011 Jan;13(1):132-42. doi: 10.1093/neuonc/noq142. Epub 2010 Oct 27.

26.

Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.

Erharter A, Giesinger J, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Sperner-Unterweger B, Holzner B.

J Pain Symptom Manage. 2010 Feb;39(2):219-29. doi: 10.1016/j.jpainsymman.2009.06.015.

PMID:
20152586
27.

Response of recurrent high-grade glioma to treatment with (90)Y-DOTATOC.

Heute D, Kostron H, von Guggenberg E, Ingorokva S, Gabriel M, Dobrozemsky G, Stockhammer G, Virgolini IJ.

J Nucl Med. 2010 Mar;51(3):397-400. doi: 10.2967/jnumed.109.072819. Epub 2010 Feb 11.

28.

Do neurooncological patients and their significant others agree on quality of life ratings?

Giesinger JM, Golser M, Erharter A, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Holzner B.

Health Qual Life Outcomes. 2009 Oct 9;7:87. doi: 10.1186/1477-7525-7-87.

29.

RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.

Beier CP, Schmid C, Gorlia T, Kleinletzenberger C, Beier D, Grauer O, Steinbrecher A, Hirschmann B, Brawanski A, Dietmaier C, Jauch-Worley T, Kölbl O, Pietsch T, Proescholdt M, Rümmele P, Muigg A, Stockhammer G, Hegi M, Bogdahn U, Hau P.

BMC Cancer. 2009 Sep 2;9:308. doi: 10.1186/1471-2407-9-308.

30.

Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.

Hutterer M, Knyazev P, Abate A, Reschke M, Maier H, Stefanova N, Knyazeva T, Barbieri V, Reindl M, Muigg A, Kostron H, Stockhammer G, Ullrich A.

Clin Cancer Res. 2008 Jan 1;14(1):130-8. doi: 10.1158/1078-0432.CCR-07-0862.

31.

Molecular therapies for malignant glioma.

Hutterer M, Gunsilius E, Stockhammer G.

Wien Med Wochenschr. 2006 Jun;156(11-12):351-63. Review.

PMID:
16944367
32.

Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study.

Hassler M, Micksche M, Stockhammer G, Pichler J, Payer F, Abuja B, Deinsberger R, Marosi C.

Wien Klin Wochenschr. 2006 May;118(7-8):230-8.

PMID:
16794761
33.

MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.

Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I, Zheng P, Bonfrer JM, Verschuuren JJ, Jenster G, Verbeek MM, Luider TM, Smitt PA.

Mol Cell Proteomics. 2005 Sep;4(9):1341-9. Epub 2005 Jun 21.

34.

Long-term cognitive and MRI findings in a patient with paraneoplastic limbic encephalitis.

Benke T, Wagner M, Pallua AK, Muigg A, Stockhammer G.

J Neurooncol. 2004 Jan;66(1-2):217-24.

PMID:
15015790
35.

Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.

Steurer M, Clausen J, Gotwald T, Gunsilius E, Stockhammer G, Gastl G, Nachbaur D.

Transplantation. 2003 Jul 27;76(2):435-6. No abstract available.

PMID:
12883208
36.

Galanin and galanin receptors in human gliomas.

Berger A, Santic R, Almer D, Hauser-Kronberger C, Huemer M, Humpel C, Stockhammer G, Sperl W, Kofler B.

Acta Neuropathol. 2003 Jun;105(6):555-60. Epub 2003 Feb 26.

PMID:
12734662
37.

Multimodality cranial image fusion using external markers applied via a vacuum mouthpiece and a case report.

Sweeney RA, Bale RJ, Moncayo R, Seydl K, Trieb T, Eisner W, Burtscher J, Donnemiller E, Stockhammer G, Lukas P.

Strahlenther Onkol. 2003 Apr;179(4):254-60.

PMID:
12707715
38.

Evoked potentials in a case of progressive multifocal leukoencephalopathy.

Kofler M, Stockhammer G, Wissel J, Golaszewski S, Poewe W.

J Neurol. 2003 Feb;250(2):236-8. No abstract available.

PMID:
12622090
39.

In vivo release of vascular endothelial growth factor from colorectal carcinomas.

Gunsilius E, Tschmelitsch J, Eberwein M, Schwelberger H, Spizzo G, Kähler CM, Stockhammer G, Lang A, Petzer AL, Gastl G.

Oncology. 2002;62(4):313-7.

PMID:
12138238
40.

Low concentrations of STI571 in the cerebrospinal fluid: a case report.

Petzer AL, Gunsilius E, Hayes M, Stockhammer G, Duba HC, Schneller F, Grünewald K, Poewe W, Gastl G.

Br J Haematol. 2002 Jun;117(3):623-5.

PMID:
12028032
41.

FACS analysis-a new and accurate tool in the diagnosis of lymphoma in the cerebrospinal fluid.

Urbanits S, Griesmacher A, Hopfinger G, Stockhammer G, Karimi A, Müller MM, Pittermann E, Grisold W.

Clin Chim Acta. 2002 Mar;317(1-2):101-7.

PMID:
11814464
42.

Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.

Gunsilius E, Petzer AL, Stockhammer G, Kähler CM, Gastl G.

Stroke. 2001 Jan;32(1):275-8. No abstract available.

PMID:
11136949
43.

Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain.

van der Flier M, Stockhammer G, Vonk GJ, Nikkels PG, van Diemen-Steenvoorde RA, van der Vlist GJ, Rupert SW, Schmutzhard E, Gunsilius E, Gastl G, Hoepelman AI, Kimpen JL, Geelen SP.

J Infect Dis. 2001 Jan 1;183(1):149-53. Epub 2000 Nov 30.

PMID:
11106541
44.

Progressive multifocal leukoencephalopathy presenting with an isolated focal movement disorder.

Stockhammer G, Poewe W, Wissel J, Kiechl U, Maier H, Felber S.

Mov Disord. 2000 Sep;15(5):1006-9.

PMID:
11009214
45.

Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression.

Stockhammer G, Obwegeser A, Kostron H, Schumacher P, Muigg A, Felber S, Maier H, Slavc I, Gunsilius E, Gastl G.

Acta Neuropathol. 2000 Jul;100(1):101-5.

PMID:
10912927
46.

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.

Gunsilius E, Duba HC, Petzer AL, Kähler CM, Grünewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J, Gastl G.

Lancet. 2000 May 13;355(9216):1688-91.

PMID:
10905245
47.

Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.

Stockhammer G, Poewe W, Burgstaller S, Deisenhammer F, Muigg A, Kiechl S, Schmutzhard E, Maier H, Felber S, Schumacher P, Gunsilius E, Gastl G.

Neurology. 2000 Apr 25;54(8):1670-6.

PMID:
10762512
48.

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood.

Gunsilius E, Petzer A, Stockhammer G, Nussbaumer W, Schumacher P, Clausen J, Gastl G.

Oncology. 2000 Feb;58(2):169-74.

PMID:
10705245
49.

Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas.

Wiesenhofer B, Stockhammer G, Kostron H, Maier H, Hinterhuber H, Humpel C.

Acta Neuropathol. 2000 Feb;99(2):131-7.

PMID:
10672319
50.

MRI findings in cerebral fat embolism.

Stoeger A, Daniaux M, Felber S, Stockhammer G, Aichner F, zur Nedden D.

Eur Radiol. 1998;8(9):1590-3.

PMID:
9866767

Supplemental Content

Loading ...
Support Center